AIGH Capital Management LLC In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 6, 2025), AIGH Capital Management LLC reported 38 stock positions worth $192.7 million . Its top holding was Verastem (VSTM) at 7.3% of the portfolio, followed by Myomo (MYO, 7.3% ) and Personalis (PSNL, 7.2% ). Compared with Q4 2024, it opened 10 new positions, sold out of 8, added to 8 and reduced 18. The biggest buy was a new position in Vishay Precision (VPG) and the biggest sale an exit from Marvell Technology (MRVL).
Location BALTIMORE, MD
CIK 0001835943
Portfolio Value $192.7M (Q1 2025) Holdings 38 stocks · $192.7M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2024 VSTM Verastem Inc. 7.31% 2,337,754 $14.1M Reduce -12.3% MYO Myomo Inc. 7.25% 2,906,689 $14.0M Reduce -14.0% PSNL Personalis Inc. 7.23% 3,968,948 $13.9M Add +4.5% ARQ Arq Inc. 5.99% 2,770,278 $11.6M Reduce -1.7% SCPH Scpharmaceuticals Inc. 5.59% 4,096,367 $10.8M Reduce -1.9% ZVRA Zevra Therapeutics Inc. 5.59% 1,438,109 $10.8M Add +82.4% BKTI BK Technologies Corp. 5.46% 268,180 $10.5M No change ELUT Elutia Inc. 4.44% 3,381,415 $8.6M Add +10.0% BLZE Backblaze Inc. Class A 4.29% 1,712,321 $8.3M Reduce -4.9% COYA Coya Therapeutics Inc. 3.97% 1,183,780 $7.7M Reduce -1.4% LPTH Lightpath Technologies Inc. Class A 3.84% 3,682,932 $7.4M Reduce -1.1% VPG Vishay Precision Group 3.29% 263,565 $6.3M New HRTX Heron Therapeutics Inc. 3.17% 2,778,200 $6.1M New HUCK Huckleberry AI Inc. filed as DOMO INC 3.03% 751,583 $5.8M New AKBA Akebia Therapeutics Inc. 2.91% 2,925,000 $5.6M New ELVA Electrovaya Inc. 2.72% 2,262,323 $5.2M Reduce -10.4% IDN Intellicheck Inc. 2.51% 1,597,538 $4.8M Reduce -1.3% ANGO Angiodynamics Inc. 2.31% 474,488 $4.5M New IPWR Ideal Power Inc. 2.21% 818,315 $4.3M Reduce -0.6% RNXT Renovorx Inc. 1.78% 3,467,275 $3.4M New DCTH Delcath Systems Inc. 1.72% 260,719 $3.3M Reduce -81.2% THTX Theratechnologies Inc. 1.69% 2,326,569 $3.3M Reduce -23.1% GRCE Grace Therapeutics Inc. 1.56% 1,322,379 $3.0M Add +153.8% BDSX Biodesix Inc. 1.39% 4,272,591 $2.7M Reduce -30.9% PYPD Polypid Ltd. 1.32% 940,381 $2.5M Add +13.6% FKWL Franklin Wireless Corp. 1.14% 385,350 $2.2M Reduce -1.2% FENC Fennec Pharmaceuticals Inc. 1.14% 361,005 $2.2M New TELA Tela Bio Inc. 0.90% 1,416,323 $1.7M Reduce -46.8% AMPG Amplitech Group Inc. 0.73% 905,453 $1.4M New APPS Digital Turbine Inc. 0.61% 430,849 $1.2M New KALA Kala Bio Inc. 0.58% 196,350 $1.1M Add +61.9% APRE Aprea Therapeutics Inc. 0.57% 539,300 $1.1M No change BIOMX INC 0.45% 1,566,944 $871K Add +81.1% SMTK Smartkem Inc. 0.44% 291,681 $855K Add +86.4% KPRX Kiora Pharmaceuticals Inc. 0.40% 253,555 $763K Reduce -0.8% BFRI Biofrontera Inc. 0.30% 732,155 $586K Reduce -9.7% INAB IN8BIO Inc. 0.12% 1,450,000 $241K Reduce -76.6% NRXS Neuraxis Inc. 0.02% 19,869 $43K New
Options reported separately and not counted above: QQQ puts ($32.8M), GLW calls ($8.0M), IWM puts ($8.0M).
Portfolio Sells Q4 2024 → Q1 2025 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2024 % Of Portfolio Change To Portfolio ▲ MRVL Marvell Technology Inc. Sold out 0.00% −6.24 TARS Tarsus Pharmaceuticals Inc. Sold out 0.00% −4.68 DCTH Delcath Systems Inc. Reduce -81.2% 1.72% −4.56 XERS Xeris Biopharma Holdings Inc. Sold out 0.00% −3.29 BDSX Biodesix Inc. Reduce -30.9% 1.39% −2.17 TELA Tela Bio Inc. Reduce -46.8% 0.90% −2.13 ARQ Arq Inc. Reduce -1.7% 5.99% −2.03 GLW Corning Inc. Sold out 0.00% −1.34 LPTH Lightpath Technologies Inc. Class A Reduce -1.1% 3.84% −1.11 MYO Myomo Inc. Reduce -14.0% 7.25% −0.94 INAB IN8BIO Inc. Reduce -76.6% 0.12% −0.47 INO Inovio Pharmaceuticals Inc. Sold out 0.00% −0.45 THTX Theratechnologies Inc. Reduce -23.1% 1.69% −0.37 CNSY Plus Therapeutics Inc. Sold out 0.00% −0.24 XAIR Beyond Air Inc. Sold out 0.00% −0.13 IPWR Ideal Power Inc. Reduce -0.6% 2.21% −0.13 MCHX Marchex Inc. Class B Sold out 0.00% −0.13 BFRI Biofrontera Inc. Reduce -9.7% 0.30% −0.03 SCPH Scpharmaceuticals Inc. Reduce -1.9% 5.59% +0.03 KPRX Kiora Pharmaceuticals Inc. Reduce -0.8% 0.40% +0.08 BLZE Backblaze Inc. Class A Reduce -4.9% 4.29% +0.21 ELVA Electrovaya Inc. Reduce -10.4% 2.72% +0.36 FKWL Franklin Wireless Corp. Reduce -1.2% 1.14% +0.42 IDN Intellicheck Inc. Reduce -1.3% 2.51% +0.81 COYA Coya Therapeutics Inc. Reduce -1.4% 3.97% +1.38 VSTM Verastem Inc. Reduce -12.3% 7.31% +2.13
Portfolio Buys Q4 2024 → Q1 2025 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2024 % Of Portfolio Change To Portfolio ▼ VPG Vishay Precision Group New 3.29% +3.29 HRTX Heron Therapeutics Inc. New 3.17% +3.17 ZVRA Zevra Therapeutics Inc. Add +82.4% 5.59% +3.11 HUCK Huckleberry AI Inc. New 3.03% +3.03 AKBA Akebia Therapeutics Inc. New 2.91% +2.91 ANGO Angiodynamics Inc. New 2.31% +2.31 RNXT Renovorx Inc. New 1.78% +1.78 FENC Fennec Pharmaceuticals Inc. New 1.14% +1.14 GRCE Grace Therapeutics Inc. Add +153.8% 1.56% +0.83 AMPG Amplitech Group Inc. New 0.73% +0.73 APPS Digital Turbine Inc. New 0.61% +0.61 PYPD Polypid Ltd. Add +13.6% 1.32% +0.38 SMTK Smartkem Inc. Add +86.4% 0.44% +0.27 KALA Kala Bio Inc. Add +61.9% 0.58% +0.27 BIOMX INC Add +81.1% 0.45% +0.21 ELUT Elutia Inc. Add +10.0% 4.44% +0.11 NRXS Neuraxis Inc. New 0.02% +0.02 PSNL Personalis Inc. Add +4.5% 7.23% −1.04
Options Activity Q4 2024 → Q1 2025 Security Type Change vs Q4 2024 Underlying Shares Value ▼ QQQ Invesco QQQ Trust Series 1 put New 70,000 $32.8M MRVL Marvell Technology Inc. call Sold out 200,000 $22.1Mbefore exit GLW Corning Inc. call Reduce -74.1% 175,000 $8.0M IWM iShares Russell 2000 ETF put New 40,000 $8.0M
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 42 $1.1B SNDK, MXL, INTC, APPS, SIMO Q1 2026 40 $488.3M SNDK, TYGO, SIMO, ZBRA, LASR Q4 2025 31 $338.3M SNDK, CSTL, PSNL, LASR, DAWN Q3 2025 34 $285.6M SNDK, PSNL, HUCK, ARQ, MXL Q2 2025 34 $213.1M PSNL, HUCK, SCPH, ARQ, VPG Q1 2025 38 $192.7M VSTM, MYO, PSNL, ARQ, SCPH Q4 2024 36 $265.7M PSNL, MYO, ARQ, DCTH, MRVL Q3 2024 37 $213.6M PSNL, SCPH, ARQ, DCTH, APPS Q2 2024 35 $204.9M SIMO, INFN, DCTH, SCPH, ARQ Q1 2024 39 $207.3M SCPH, OUST, ELVA, CLRB, DCTH